MicroRNA-141 is a tumor regulator and prognostic biomarker in human glioblastoma.

Abstract

Human glioblastoma is one of the most malignant types of brain tumor in the world. In the present study, the functional mechanisms of microRNA-141 (miR-141) were assessed, and the potential role of miR-141 as a prognostic biomarker in glioblastoma was examined. The gene expression of miR-141 in glioblastoma cell lines and glioblastoma tumors was assessed by reverse transcription-quantitative polymerase chain reaction. Glioblastoma LN229 and U89 cell lines were transfected with synthetic miR-141 mimics to upregulate endogenous miR-141. The subsequent effect on glioblastoma proliferation was assessed by MTT assay. In human glioblastoma, miR-141 expression was compared between patients with tumors of different pathological grades. Statistical analyses were performed to assess the correlation between miR-141 and the clinicopathological properties and overall survival rates (OS) of the patients. In addition, a Cox regression model was used to examine whether miR-141 was a potential biomarker of glioblastoma. miR-141 was aberrantly downregulated in glioblastoma cell lines and human glioblastoma tumors. Forced miR-141 upregulation in glioblastoma LN229 and U89 cell lines suppressed cancer proliferation. In patients with glioblastoma, miR-141 downregulation was closely associated with an advanced disease stage, poor clinicopathological properties and a shorter OS time. The multivariate Cox regression model demonstrated that low miR-141 expression was an effective prognostic biomarker for patients with glioblastoma. Overall, the present study showed that miR-141 may be a functional cancer regulator and a prognostic biomarker for glioblastoma.